Literature DB >> 19345996

Real-time consensus on relapse risk in acute promyelocytic leukemia.

Robert E Gallagher.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19345996      PMCID： PMC2756678          DOI： 10.1016/j.leukres.2009.03.014

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  12 in total

1.  Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.

Authors:  Robert E Gallagher; Beow Y Yeap; Wanli Bi; Kenneth J Livak; Nike Beaubier; Sreenivas Rao; Clara D Bloomfield; Frederick R Appelbaum; Martin S Tallman; James L Slack; Cheryl L Willman
Journal:  Blood       Date:  2002-12-05       Impact factor: 22.113

2.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

3.  Therapy of molecular relapse in acute promyelocytic leukemia.

Authors:  F Lo Coco; D Diverio; G Avvisati; M C Petti; G Meloni; E M Pogliani; A Biondi; G Rossi; C Carlo-Stella; C Selleri; B Martino; G Specchia; F Mandelli
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

Review 4.  Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia.

Authors:  Miguel A Sanz; Martin S Tallman; Francesco Lo-Coco
Journal:  Blood       Date:  2004-12-16       Impact factor: 22.113

5.  Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Authors:  M A Sanz; F Lo Coco; G Martín; G Avvisati; C Rayón; T Barbui; J Díaz-Mediavilla; G Fioritoni; J D González; V Liso; J Esteve; F Ferrara; P Bolufer; C Bernasconi; M Gonzalez; F Rodeghiero; D Colomer; M C Petti; J M Ribera; F Mandelli
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

6.  Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia.

Authors:  Carlos Santamaría; Maria Carmen Chillón; Carina Fernández; Patricia Martín-Jiménez; Ana Balanzategui; Ramón García Sanz; Jesús F San Miguel; Marcos-Gonzalez González
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

Review 7.  Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

Authors:  J Gabert; E Beillard; V H J van der Velden; W Bi; D Grimwade; N Pallisgaard; G Barbany; G Cazzaniga; J M Cayuela; H Cavé; F Pane; J L E Aerts; D De Micheli; X Thirion; V Pradel; M González; S Viehmann; M Malec; G Saglio; J J M van Dongen
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

8.  Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.

Authors:  D Diverio; V Rossi; G Avvisati; S De Santis; A Pistilli; F Pane; G Saglio; G Martinelli; M C Petti; A Santoro; P G Pelicci; F Mandelli; A Biondi; F Lo Coco
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

9.  Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Authors:  Miguel A Sanz; Guillermo Martín; Marcos González; Angel León; Chelo Rayón; Concha Rivas; Dolors Colomer; Elena Amutio; Francisco J Capote; Gustavo A Milone; Javier De La Serna; José Román; Eva Barragán; Juan Bergua; Lourdes Escoda; Ricardo Parody; Silvia Negri; María J Calasanz; Pascual Bolufer
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

10.  When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).

Authors:  Bruno Cassinat; Stéphane de Botton; Charikleia Kelaidi; Lionel Ades; Fabien Zassadowski; Isabelle Guillemot; Marie-Helene Schlageter; Emmanuel Raffoux; Jean-Luc Harousseau; Olivier Legrand; Martine Escoffre-Barbe; Oumedaly Reman; Martine Gardembas; Chantal Himberlin; Jean Yves Cahn; Denis Guyotat; Didier Bouscary; Anne Parry; Philippe Rousselot; Andre Baruchel; Hervé Dombret; Sylvie Chevret; Pierre Fenaux; Christine Chomienne
Journal:  Leuk Res       Date:  2009-01-23       Impact factor: 3.156
View more
  1 in total

Review 1.  Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia.

Authors:  Margaret L Gulley; Thomas C Shea; Yuri Fedoriw
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.